China Has Huge Capacity to Produce Vaccines: RAND's Bouey

The video discusses the criticism of China's handling of the COVID-19 pandemic, highlighting the political implications and challenges faced by WHO investigators. It explores China's vaccine production capacity, noting its achievements and the regulatory hurdles it faces to meet international standards. The video also addresses the mistrust and quality concerns surrounding Chinese products, emphasizing the need for China to meet WHO pre-qualification requirements to regain trust in developing economies.

What challenges did WHO investigators face when trying to access China for their investigations?

• Lack of funding

• Political interference

• Language barriers

• Travel restrictions

Before COVID-19, what was China's capacity for vaccine production?

• 1 billion doses

• 1.5 billion doses

• 700 million doses

• 500 million doses

Which international committee did China join in 2017 to improve its pharmaceutical standards?

• UNICEF

• CH

• WHO

• FDA

What is one of the main reasons for the mistrust of Chinese vaccines in the international market?

• Limited availability

• High cost

• Lack of clinical trial data in English

• Poor marketing strategies

What is required for a vaccine to achieve WHO pre-qualification?

• Endorsement by international celebrities

• Publication of clinical trial data in English

• Approval from local governments

• A minimum production capacity